It is a pharma private limited company based in Thane, Maharashtra, India, established in 2000.
2000 | Thane, Maharashtra, India | ActiveSatyam Generic Pharma Private Limited, a active private limited company, was established on 27 November 2000 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397MH2000PTC129773. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.94 M.
It upholds a active non-compliant status. Its leadership includes Dhroov Dinesh Singh (Director), Dinesh Amar Bahadur Singh (Director), Brijesh Amar Bahadur Singh (Director). Past directors included Dhroov Dinesh Singh, Amar Bahadur Chandrabali Singh. It holds ₹5.33 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 101/A Ruchi Apartmentsr N P Park Bhayander (East), Thane, Maharashtra, 401105.
U51397MH2000PTC129773
129773
27 November 2000
₹2.00 M
₹0.94 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Satyam Generic Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhroov Dinesh Singh | Director | 15 Mar 2022 | Current |
| Dinesh Amar Bahadur Singh | Director | 27 Nov 2000 | Current |
| Brijesh Amar Bahadur Singh | Director | 27 Nov 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Mar 2023 | Past |
| Pramod Abcsdd | Director | 30 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Satyam Generic Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.75% increase. The company also saw a substantial improvement in profitability, with a 75.77% increase in profit. The company's net worth Soared by an impressive increase of 26.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Satyam Generic Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹53,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2012 | Others | ₹2.90 Cr | Open |
| 30 Jul 2009 | Ing Vysya Bank Limited | ₹1.25 Cr | Open |
| 18 Nov 2006 | Indusind Bank Limited | ₹7.50 M | Open |
| 11 Apr 2002 | Central Bank Of India | ₹4.30 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Satyam Generic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Satyam Generic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyam Generic Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Satyam Generic Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Satyam Generic Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Dhroov Dinesh Singh was appointed as a Director was appointed as a Director on 15 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
A charge with Others of Rs. 29.00 M registered on 23 May 2012 with Charge ID 10359506 was modified on 03 May 2016. was recorded as a recent event.
A charge with Others amounted to Rs. 29.00 M with Charge ID 10359506 was registered on 23 May 2012. was recorded as a recent event.
The activity A charge with Ing Vysya Bank Limited amounted to Rs. 12.50 M with Charge ID 10177261 was registered on 30 Jul 2009. was completed.
The CIN of Satyam Generic Pharma Private Limited is U51397MH2000PTC129773.
Satyam Generic Pharma Private Limited is headquartered at 101/A Ruchi Apartmentsr N P Park Bhayander (East), Thane, Maharashtra, 401105.
Satyam Generic Pharma Private Limited was incorporated on 27 November 2000.
The current directors of Satyam Generic Pharma Private Limited are
The primary industry of Satyam Generic Pharma Private Limited is Trade.
Satyam Generic Pharma Private Limited is unlisted.
The authorized capital of Satyam Generic Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹0.94 M.
The compliance status of Satyam Generic Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX